We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

37 hedge funds and large institutions have $18.3M invested in BIND THERAPEUTICS INC in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 4037 (-3)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

51% less capital invested

Capital invested by funds: $37.4M → $18.3M (-$19M)

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
13
Reduced
10
Closed
11
Calls
Puts
Net Calls
Net Calls Change

BIND Hedge Fund Activity: Q4 2014 in Review

37 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q4 2014, worth a combined $18.3M — down 51% from $37.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of BIND and 9 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 13 added.

The largest buyer was Spark Investment Management, opening a new position worth an estimated $419K. The largest seller was Opaleye Management, exiting entirely with an estimated $3.87M sold.

  • 37 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q4 2014, down from 40 in Q3 2014.
  • Funds reported $18.3M of BIND THERAPEUTICS INC stock for Q4 2014, down 51% quarter-over-quarter.
  • 9 funds opened new BIND THERAPEUTICS INC positions in Q4 2014 and 11 closed out, a net change of -2 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q4 2014 was Spark Investment Management, an estimated $419K added.
  • The largest BIND THERAPEUTICS INC seller in Q4 2014 was Opaleye Management, an estimated $3.87M sold.

Based on aggregated 13F filings for Q4 2014.